Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

Ann Oncol. 2009 Mar;20(3):595-6. doi: 10.1093/annonc/mdn771. Epub 2009 Jan 19.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Docetaxel
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Taxoids / administration & dosage
  • Taxoids / therapeutic use*

Substances

  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Docetaxel